Anticoagulant heparan sulfate: structural specificity and biosynthesis (original) (raw)
Aikawa J-i, Grobe K, Tsujimoto M, Esko JD (2001) Multiple isozymes of heparan sulfates/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4. J Biol Chem 276:5876–5882 CASPubMed Google Scholar
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279:12346–12354 CASPubMed Google Scholar
Atha DH, Lormeau J-C, Petitou M, Rosenberg RD, Choay J (1985) Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24:6723–6729 CASPubMed Google Scholar
Avci FY, Karst NA, Linhardt RJ (2003) Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties. Curr Pharm Des 9:2323–2335 CASPubMed Google Scholar
Balagurunathan K, Beeler DL, Lech M, Wu ZL, Rosenberg RD (2003a) Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides. J Biol Chem 278:52613–52621 Google Scholar
Becker RC (2004) Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis 18:55–58 CASPubMed Google Scholar
Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–777 CASPubMed Google Scholar
Burkart MD, Izumi M, Chapman E, Lin C, Wong C (2000) Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides. J Org Chem 65:5565–5574 CASPubMed Google Scholar
Chen J, Duncan MB, Carrick K, Pope M, Liu J (2003) Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. Glycobiology 13:785–794 CASPubMed Google Scholar
Chen J, Avci FY, Muñoz EM, McDowell LM, Chen M, Pedersen LC, Zhang L, Linhardt RJ, Liu J (2005) Enzymatically redesigning of biologically active heparan sulfate. J Biol Chem 280:42817–42825 CASPubMed Google Scholar
Coombe DR, Kett WC (2005) Heparan sulfate-protein interactions: therapeutic potential through structure–function insights. Cell Mol Life Sci 62:410–424 CASPubMed Google Scholar
Das S, Mallet J, Esnault J, Driguez P, Duchaussoy P, Sizun P, Herault J, Herbert J, Petitou M, Sinay P (2001) Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin. Chemistry 7:4821–4834 CASPubMed Google Scholar
de Paz JL, Noti C, Seeberger PH (2006) Microarrays of synthetic heparin oligosaccharides. J Am Chem Soc 128:2766–2767 PubMed Google Scholar
Dementiev A, Petitou M, Herbert J-M, Gettins PG (2004) The ternary complex of antithrombin–anhydrothrombin–heparin reveals the basis of inhibitor specificity. Nat Struct Biol 11:867–863 CAS Google Scholar
Duncan MB, Chen J, Krise JP, Liu J (2004) The biosynthesis of anticoagulant heparan sulphate by the heparan sulphate 3-O-sulphotransferase isoform 5. Biochim Biophys Acta 1671:34–43 CASPubMed Google Scholar
Edavettal SC, Lee KA, Negishi M, Linhardt RJ, Liu J, Pedersen LC (2004) Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem 279:25789–25797 CASPubMed Google Scholar
Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435–471 CASPubMed Google Scholar
Ferro V, Don R (2003) The development of the novel angiogenesis inhibitor PI-88 as an anticancer drug. Australas Biotechnol 13:38–39 CAS Google Scholar
Gettins PG (2002) Serpin structure, mechanism, and function. Chem Rev 102:4751–4803 CASPubMed Google Scholar
Habuchi H, Habuchi O, Kimata K (1995) Purification and characterization of heparan sulfate 6-sulfotransferase from the culture medium of Chinese hamster ovary cells. J Biol Chem 270:4172 CASPubMed Google Scholar
Habuchi H, Tanaka M, Habuchi O, Yoshida K, Suzuki H, Ban K, Kimata K (2000) The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 275:2859–2868 CASPubMed Google Scholar
Hacker U, Nybakken K, Perrimon N (2005) Heparan sulfate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 6:530–541 PubMed Google Scholar
HajMohammadi S, Enjyoji K, Princivalle M, Christi P, Lech M, Beeler DL, Rayburn H, Schwartz JJ, Barzegar S, de Agostini AI, Post MJ, Rosenberg RD, Shworak NW (2003) Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest 111:989–999 CASPubMedPubMed Central Google Scholar
Herbert JM, Herault JP, Bernat A, Savi P, Schaeffer P, Driguez PA, Duchaussov P, Petitou M (2001) SR 123781A, a synthetic heparin mimetic. Thromb Haemost 85:852–860 CASPubMed Google Scholar
Hirsh J, O’Donnell M, Weitz JI (2005) New anticoagulants. Blood 105:453–463 CASPubMed Google Scholar
Ishihara M, Guo Y, Wei Z, Yang Z, Swiedler SJ, Orellana A, Hirschberg CB (1993) Regulation of biosynthesis of the basic fibroblast growth factor binding domains of heparan sulfate by heparan sulfate-_N_-deacetylase/_N_-sulfotransferase expression. J Biol Chem 268:20091–20095 CASPubMed Google Scholar
Jin L, Abrahams P, Skinner R, Petitou M, Pike RN, Carrell RW (1997) The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA 94:14683–14688 CASPubMedPubMed Central Google Scholar
Kelton JG (2002) Heparin-induced thrombocytopenia: an overview. Blood Rev 16:77–80 CASPubMed Google Scholar
Kobayashi M, Habuchi H, Habuchi O, Saito M, Kimata K (1996) Purification and characterization of heparan sulfate 2-sulfotransferase from cultured Chinese hamster ovary cells. J Biol Chem 271:7645–7653 CASPubMed Google Scholar
Kraulis PJ (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946–950 Google Scholar
Kuberan B, Beeler DL, Lawrence R, Lech M, Rosenberg R (2003) Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin. J Am Chem Soc 125:12424–12425 CASPubMed Google Scholar
Lee JC, Lu XA, Kulkarni SS, Wen YS, Hung SC (2004) Synthesis of heparin oligosaccharides. J Am Chem Soc 126:476–477 CASPubMed Google Scholar
Li W, Johnson DJ, Esmon CT, Huntington JA (2004) Structure of the antithrombin–thrombin–heparin ternary complex reveals the anti-thrombotic mechanism of heparin. Nat Struct Mol Biol 11:857–862 CASPubMed Google Scholar
Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 273:26265–26268 CASPubMed Google Scholar
Lindahl U, Kusche-Gullberg M, Kjellen L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273:24979–24982 CASPubMed Google Scholar
Lindahl U, Li J, Kusche-Gullberg M, Salmivirta M, Alaranta S, Veromaa T, Emies J, Roberts I, Taylor C, Oreste P et al (2005) Generation of “neoheparin” from E. Coli K5 capsular polysaccharide. J Med Chem 48:349–352 CASPubMed Google Scholar
Liu J, Rosenberg RD (2002) Heparan sulfate D-glucosaminyl 3-_O_-sulfotransferase. In: N Taniguchi, M Fukuda (eds) Handbook of glycosyltransferases and their related genes. Springer, Berlin Heidelberg New York, pp 475–483 Google Scholar
Liu J, Thorp SC (2002) Heparan sulfate and the roles in assisting viral infections. Med Res Rev 22:1–25 PubMed Google Scholar
Liu J, Shworak NW, Fritze LMS, Edelberg JM, Rosenberg RD (1996) Purification of heparan sulfate D-glucosaminyl 3-_O_-sulfotransferase. J Biol Chem 271:27072–27082 CASPubMed Google Scholar
McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP, Tufaro F (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19:158–161 CASPubMed Google Scholar
Merritt EA, Bacon DJ (1997) Raster3D: photorealistic molecular graphics. Methods Enzymol 277:505–524 CASPubMed Google Scholar
Mikhailov D, Mayo KH, Pervin A, Linhardt RJ (1996) 13C-NMR relaxation study of heparin–disaccharide interactions with tripeptide GRG and GKG. Biochem J 315:447–454 CASPubMedPubMed Central Google Scholar
Moon A, Edavettal SC, Krahn JX, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC (2004) Structural analysis of the sulfotransferase (3-OST-3) involved in the biosynthesis of an entry receptor of herpes simplex virus 1. J Biol Chem 279:45185–45193 CASPubMed Google Scholar
Mulloy B, Forster M (2000) Conformation and dynamics of heparin and heparan sulfate. Glycobiology 10:1147–1156 CASPubMed Google Scholar
Nyberg K, Ekblad M, Bergstrom T, Freeman C, Parish CR, Ferro V, Trybala E (2004) The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res 63:15–24 CASPubMed Google Scholar
Oosta GM, Gardner WT, Beeler DL, Rosenberg R (1981) Multiple functional domains of the heparin molecule. Proc Natl Acad Sci USA 78:829–833 CASPubMedPubMed Central Google Scholar
Petitou M, van Boeckel CAA (1992) Chemical synthesis of heparin fragments and analogues. Fortschr Chem Org Naturst 60:143–210 CASPubMed Google Scholar
Petitou M, van Boeckel CAA (2004) A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew Chem Int Ed 43:3118–3133 CAS Google Scholar
Petitou M, Herault L-P, Bernat A, Driguez P-A, Duchaussoy P, Lormeau J-C, Herbert J-M (1999) Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 398:417–422 CASPubMed Google Scholar
Raman R, Sasisekharan V, Sasisekharan R (2005) Structural insights into biological roles of protein–glycosaminoglycan interactions. Chem Biol 12:267–277 CASPubMed Google Scholar
Rosenberg RD, Showrak NW, Liu J, Schwartz JJ, Zhang L (1997) Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J Clin Invest 99:2062–2070 CASPubMedPubMed Central Google Scholar
Sanderson RD, Yang Y, Suva LJ, Kelly T (2004) Heparan sulfate proteglycans and heparanase—partners in osteolytic tumor growth and metastasis. Matrix Biol 23:341–352 CASPubMed Google Scholar
Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U (2002) Roles of heparin-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2:521–528 CASPubMed Google Scholar
Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13–22 CASPubMed Google Scholar
Shworak NW, Liu J, Fritze LMS, Schwartz JJ, Zhang L, Logeart D, Rosenberg RD (1997) Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-_O_-sulfotransferase. J Biol Chem 272:28008–28019 CASPubMed Google Scholar
Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA, Rosenberg RD (1999) Diversity of the extensive heparan sulfate D-glucosaminyl 3-_O_-sulfotransferase (3-OST) multigene family. J Biol Chem 274:5170–5184 CASPubMed Google Scholar
Smeds E, Habuchi H, Do A-T, Hjertson E, Grundberg H, Kimata K, Lindahl U, Kusche-Gullberg M (2003) Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulfotransferases. Biochem J 372(Pt 2):371–380 CASPubMedPubMed Central Google Scholar
Taylor KR, Gallo RL (2006) Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20:9–22 CASPubMed Google Scholar
Xia G, Chen J, Tiwari V, Ju W, Li J-P, Malmström A, Shukla D, Liu J (2002) Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem 277:37912–37919 CASPubMed Google Scholar
Xu D, Tiwari V, Xia G, Clement C, Shukla D, Liu J (2005) Characterization of heparan sulfate 3-O-sulfotransferase isoform 6 and its role in assisting the entry of herpes simplex virus, type 1. Biochem J 385:451–459 CASPubMedPubMed Central Google Scholar